Desogestrel contraceptives: 1.6 million French women warned of tumour risk
The French medicines agency (ANSM) urges women who take desogestrel contraceptives to seek medical advice if they develop suggestive symptoms, such as persistent headaches, visual disturbances or memory loss.
Implicity, an AI-driven cardiac remote monitoring company based in Paris, has secured €35 million in funding to expand internationally, with a focus on the USA. The round was led by IRIS and Five Arrows, with the startup's CEO and co-founder, Dr. Arnaud Rosier, stating that the investment will allow them to care for patients at scale.
The funding comes amid a surge in investment in European cardiac care, remote patient monitoring, and AI-enabled MedTech in 2026, with EU-Startups reporting €209.6 million in relevant financings this year alone. France has been particularly active, with startups like DentalMonitoring, Lifeaz, and FineHeart securing significant funding for their health technologies.
Implicity's platform aggregates, normalises, and analyses cardiac data from various device manufacturers, demonstrating a 26% reduction in mortality and a 4% reduction in hospitalisation. The company aims to become the leading platform for remote monitoring in cardiology, expanding into new verticals as its technology proves successful in the field.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
